Oliver Bogler

MD Anderson Cancer Centre, University of Texas

Affiliated withUniversity of Texas University of Texas MD Anderson Cancer Center University of Texas MD Anderson Cancer Center

Research Area

Medicine

Biography

Oliver Bogler has not added Biography.
If you are Oliver Bogler and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 14	2011
Publication title Cited by 60	2018

Other Publications

Article	Year
Studying the heterogeneity of brain tumors using medium throughput LOH analysis. Cytometry\| PubMed ID: 11774351	2002
A novel seven transmembrane receptor induced during the early steps of astrocyte differentiation identified by differential expression. Journal of neurochemistry\| PubMed ID: 12065666	2002
Apoptosis in gliomas, and its role in their current and future treatment. Frontiers in bioscience : a journal and virtual library\| PubMed ID: 12133814	2002
The proliferation marker pKi-67 organizes the nucleolus during the cell cycle depending on Ran and cyclin B. The Journal of pathology\| PubMed ID: 12474222	2003
Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 12734385	2003
SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. Journal of cell science\| PubMed ID: 12771190	2003
Angiogenesis in glioma: molecular mechanisms and roadblocks to translation. Cancer journal (Sudbury, Mass.)\| PubMed ID: 12952305	2003
Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14555516	2003
Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14555517	2003
p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding. Cancer research\| PubMed ID: 14583449	2003
Constitutive EGFR signaling confers a motile phenotype to neural stem cells. Molecular and cellular neurosciences\| PubMed ID: 14697673	2003
Proliferation marker pKi-67 occurs in different isoforms with various cellular effects. Journal of cellular biochemistry\| PubMed ID: 15048881	2004
Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Molecular and cellular biology\| PubMed ID: 15456872	2004
Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies. Biochemical and biophysical research communications\| PubMed ID: 15522216	2004
Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. The Journal of biological chemistry\| PubMed ID: 15557335	2005
Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles. Molecular & cellular proteomics : MCP\| PubMed ID: 15951525	2006
Angiogenesis and apoptosis in glioma: two arenas for promising new therapies. Journal of cellular biochemistry\| PubMed ID: 16052525	2005
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma. Neuro-oncology\| PubMed ID: 16723633	2006
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16899617	2006
Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins. The Biochemical journal\| PubMed ID: 16978157	2007
Proteomic comparison of oligodendrogliomas with and without 1pLOH. Cancer biology & therapy\| PubMed ID: 17264672	2007
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy\| PubMed ID: 18259115	2008
Biomarkers and cancer stem cells in primary brain tumors. Foreword. Current problems in cancer\| PubMed ID: 18501773	2008
Proteomics: the new frontier also for brain tumor research. Current problems in cancer\| PubMed ID: 18501776	2008
Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. International journal of cancer. Journal international du cancer\| PubMed ID: 19048625	2009
Exploratory analysis of the copy number alterations in glioblastoma multiforme. PloS one\| PubMed ID: 19115005	2008
Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity. Autophagy\| PubMed ID: 19270491	2009
Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer research\| PubMed ID: 19920199	2009
Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma. International journal of cancer. Journal international du cancer\| PubMed ID: 20473884	2011
CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice. The EMBO journal\| PubMed ID: 20551902	2010
The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells. Neuro-oncology\| PubMed ID: 20713409	2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. The Journal of clinical investigation\| PubMed ID: 21183793	2011
Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of Î”EGFR. Journal of proteome research\| PubMed ID: 21214269	2011
Forced dimerization increases the activity of Î”EGFR/EGFRvIII and enhances its oncogenicity. Molecular cancer research : MCR\| PubMed ID: 21775422	2011
Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated Î²-catenin to the nucleus. Journal of cellular biochemistry\| PubMed ID: 21866566	2012
Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma. Molecular pharmacology\| PubMed ID: 21908708	2011
Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter. International journal of cancer\| PubMed ID: 22729867	2013
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro-oncology\| PubMed ID: 22753228	2012
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells. Neoplasia (New York, N.Y.)\| PubMed ID: 23359207	2013
Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis. International journal of cancer\| PubMed ID: 25302990	2015
Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells. Journal of translational medicine\| PubMed ID: 26861698	2016
mA Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer cell\| PubMed ID: 28344040	2017